Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 497641 - 497660 out of 558234 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Sweden | (L04AA26) belimumab | Benlysta | 4, 200 mg , Förfylld injektionspenna, 4 st | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKlineAB |
| Sweden | (L04AA26) belimumab | Benlysta | 1, 200 mg , Förfylld injektionspenna, 1 st | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSmithKlineAB |
| Sweden | (L04AA26) belimumab | Benlysta | 4, 200 mg , Förfylld injektionspenna, 4 st (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | ParanovaLäkemedelAB |
| Sweden | (L04AA29) tofacitinib | XELJANZ | 240, 1 mg/ml , Flaska, 240 ml | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | PfizerAB |
| Sweden | (L04AA29) tofacitinib | XELJANZ | 56, 10 mg , Blister, 56 tabletter (kalenderförpackning) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | PfizerAB |
| Sweden | (L04AA29) tofacitinib | XELJANZ | 112, 10 mg , Blister, 112 tabletter (kalenderförpackning) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | PfizerAB |
| Sweden | (L04AA29) tofacitinib | XELJANZ | 112, 10 mg , Blister, 112 tabletter (kalenderförpackning) (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | ParanovaLäkemedelAB |
| Sweden | (L04AA29) tofacitinib | XELJANZ | 90, 11 mg , Burk. 90 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | PfizerAB |
| Sweden | (L04AA29) tofacitinib | XELJANZ | 28, 11 mg , Blister, 28 tabletter (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | ParanovaLäkemedelAB |
| Sweden | (L04AA29) tofacitinib | XELJANZ | 180, 5 mg , Burk, 180 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | PfizerAB |
| Sweden | (L04AA29) tofacitinib | XELJANZ | 56, 5 mg , Blister, 56 x 1 tabletter (endos) (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | ParanovaLäkemedelAB |
| Sweden | (L04AA32) apremilast | Otezla | 56, 30 mg , Blister, 56 tabletter (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic; Psoriasis | ParanovaLäkemedelAB |
| Sweden | (L04AA38) ozanimod | Zeposia | 7, 0,23 mg + 0,46 mg , Blister, 4 kaps 0,23 mg + 3 kaps 0,46 mg | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting; Colitis, Ulcerative | Bristol-MyersSquibbAB |
| Sweden | (L04AA38) ozanimod | Zeposia | 28, 0,92 mg , Blister, 28 kapslar | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting; Colitis, Ulcerative | Bristol-MyersSquibbAB |
| Sweden | (L04AA40) cladribine | MAVENCLAD | 6, 10 mg , Blister, 6 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | MerckAB |
| Sweden | (L04AA40) cladribine | MAVENCLAD | 1, 10 mg , Blister, 1 tablett | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | MerckAB |
| Sweden | (L04AA40) cladribine | MAVENCLAD | 4, 10 mg , Blister, 4 tabletter | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | MerckAB |
| Sweden | (L04AA40) cladribine | MAVENCLAD | 4, 10 mg , Blister, 4 tabletter (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | ParanovaLäkemedelAB |
| Sweden | (L04AA40) cladribine | MAVENCLAD | 6, 10 mg , Blister, 6 tabletter (PD Paranova Läkemedel AB) | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | ParanovaLäkemedelAB |
| Sweden | (L04AB01) etanercept | Benepali | 4, 25 mg , Förfylld spruta, 4 x 1 st | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Psoriatic; Arthritis, Rheumatoid; Psoriasis | BiogenSwedenAB |
Pages
